Health Canada
- Status: approved
🇨🇦 Sildenafil therapy plus post-NSRRP HBO2T in Canada
Sildenafil therapy plus post-NSRRP HBO2T (Sildenafil therapy plus post-NSRRP HBO2T) regulatory status in Canada.
Marketing authorisation
Sildenafil therapy plus post-NSRRP HBO2T in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Sildenafil therapy plus post-NSRRP HBO2T approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Sildenafil therapy plus post-NSRRP HBO2T in Canada?
Hartford Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.